// Weight Loss

Tirzepatide

Dual GLP-1 + GIP agonist. In head-to-head studies, more weight loss on average than GLP-1 alone.

✓Dual incretin pathway · GIP + GLP-1 receptor activation
✓Injectable + ODT formats · weekly or daily protocols
✓Compounded under USP 797 sterile standards
✓Same active molecule as Mounjaro / Zepbound

Starting from

Sign-in required. A licensed physician reviews every prescription before it ships.

// All formulations

16 formulations available

For orientation only — your physician confirms the final protocol on the pharmacy storefront.

Option	Dose	Size	Price
ODT starter · 30 ct	0.5 mg	30 tablets	$88
Starter injectable · 1 mL	10 mg/mL	1 mL vial	$88
Mid-dose injectable · 1 mL	15 mg/mL	1 mL vial	$103
ODT starter · 60 ct	0.5 mg	60 tablets	$119
Standard injectable · 2 mL	10 mg/mL	2 mL vial	$119
High-dose injectable · 1 mL	20 mg/mL	1 mL vial	$119
ODT starter · 90 ct	0.5 mg	90 tablets	$150
Standard injectable · 3 mL	10 mg/mL	3 mL vial	$155
Mid-dose injectable · 2 mL	15 mg/mL	2 mL vial	$155
Standard injectable · 4 mL	10 mg/mL	4 mL vial	$196
Mid-dose injectable · 3 mL	15 mg/mL	3 mL vial	$201
Standard injectable · 5 mL	10 mg/mL	5 mL vial	$227
Mid-dose injectable · 4 mL	15 mg/mL	4 mL vial	$248
High-dose injectable · 3 mL	20 mg/mL	3 mL vial	$248
Mid-dose injectable · 5 mL	15 mg/mL	5 mL vial	$277
High-dose injectable · 5 mL	20 mg/mL	5 mL vial	$304

Compounded by Greenstone Rx · Florida 503A pharmacy

Continue to Pharmacy →

// The science

About Tirzepatide

Tirzepatide activates both GIP and GLP-1 receptors — the same dual pathway as branded Mounjaro and Zepbound. In SURPASS and SURMOUNT trials, tirzepatide demonstrated greater average weight loss than semaglutide. Available compounded in injectable and ODT formats across starter, standard, and maintenance doses.

// How it works

How it works

Tirzepatide activates two gut-hormone receptors: GLP-1 (the same one semaglutide hits) and GIP. The GIP component appears to amplify the appetite-suppression and metabolic effects, which is why head-to-head studies show greater average weight loss.

// Who it's for

Who it's for

Adults with significant weight to lose, particularly those who've tried a GLP-1 alone and found the results good but incomplete. Patients with type 2 diabetes — tirzepatide also has strong glycemic data.

// What to expect

Your timeline

Weeks 1–4
Starter dose (2.5 mg). Modest appetite reduction. Mild GI side effects.
Weeks 4–16
Step-ups every 4 weeks: 5 mg → 7.5 mg → 10 mg. Each step has a few days of GI adjustment.
Months 4–12
Most patients land at 10–15 mg. 15–20% body weight loss is common in clinical data.

// Who should not take this

Who should not take this

Same as semaglutide: medullary thyroid carcinoma history, MEN-2, pregnancy, active pancreatitis, severe gallbladder disease.

// Typical starting dose

Typical starting dose

A typical starting protocol is 2.5 mg once weekly for the first month, with stepped increases of 2.5 mg every 4 weeks as tolerated. Suggestions only — your physician reviews and approves the final protocol before any medication ships.

// Ready when you are

Start your prescription.

You'll complete a short health screening on the pharmacy storefront. A licensed physician reviews every order before any medication ships.

Continue to Pharmacy →

Compounded by a 503A licensed pharmacy pursuant to a valid prescription. Not an FDA-approved drug. Not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Full disclaimer.